Chris Wiethoff is a Senior Director at Eli Lilly, where they apply expertise in pharmaceutics, biologics formulation, and bioanalysis to develop therapeutics for immunological, metabolic, and neurodegenerative diseases. They previously served as a Senior Advisor and Director at Eli Lilly, following an academic career as an Assistant Professor at Loyola University Medical Center, where they directed research in viral vaccine vector development. Earlier in their career, they contributed to research on adenovirus mechanisms as a Research Associate at The Scripps Research Institute. Chris holds a Pharm.D. from the University of Michigan and a Ph.D. in Pharmaceutical Chemistry from The University of Kansas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices